4.82
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Abeona Therapeutics Inc Borsa (ABEO) Ultime notizie
Panic Selling: Should I set a stop loss on Abeona Therapeutics Inc2026 Chart Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York - sahmcapital.com
ABEO PE Ratio & Valuation, Is ABEO Overvalued - Intellectia AI
New York hospital joins Abeona network for blistering skin therapy - Stock Titan
ABEO Should I Buy - Intellectia AI
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2025 earnings call transcript - MSN
ABEO Technical Analysis & Stock Price Forecast - Intellectia AI
Insider Sell: Vishwas Seshadri Sells 29,985 Shares of Abeona The - GuruFocus
Abeona Therapeutics CEO Seshadri Vishwas sells $131k in stock - Investing.com
Abeona (ABEO) CEO sells 29,985 shares under Rule 10b5-1 plan - Stock Titan
ABEO (NASDAQ: ABEO) Form 144: 29,985 restricted shares proposed sale - Stock Titan
Daniel Kaufman files Schedule 13G — Abeona (NASDAQ: ABEO) 5.16% stake - Stock Titan
Vanguard disaggregates holdings; ABEO ownership shown as 0 (ABEO) - Stock Titan
Meme Stocks: Does Abeona Therapeutics Inc have strong EBITDA margins2026 Earnings Surprises & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
HC Wainwright Issues Pessimistic Outlook for ABEO Earnings - MarketBeat
Oppenheimer Maintains Outperform on Abeona Therapeutics (ABEO) PT $22 March 2026 - Meyka
Abeona Therapeutics Adopts Third Amended and Restated Bylaws Effective March 16, 2026 - Minichart
Form 8K Abeona Therapeutics Inc For: 20 March By Investing.com - Investing.com Australia
Form 8K Abeona Therapeutics Inc For: 20 March - Investing.com
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules - TipRanks
Abeona (NASDAQ: ABEO) tightens bylaws on meetings and director nominations - Stock Titan
Abeona Therapeutics Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Abeona Therapeutics Earnings Notes - Trefis
Abeona Therapeutics: Maintaining 'Buy' On ZEVASKYN Launch Potential For RDEB - Seeking Alpha
HC Wainwright & Co. Reiterates Buy Rating for Abeona Therapeutics (ABEO) | ABEO Stock News - GuruFocus
Abeona Therapeutics (NASDAQ:ABEO) Earns Buy Rating from HC Wainwright - MarketBeat
Abeona Therapeutics (ABEO) Receives a Buy from Oppenheimer - The Globe and Mail
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2025 Earnings Call Transcript - Insider Monkey
Abeona Therapeutics Balances Big Windfall With Slow Ramp - The Globe and Mail
Abeona Therapeutics: Early Zevaskyn Revenue Marks A Key Inflection Point (NASDAQ:ABEO) - Seeking Alpha
Abeona Therapeutics (ABEO) One Off US$152.4m Gain Tests Bullish Profitability Narrative - simplywall.st
Abeona targets activation of 7 QTCs for ZEVASKYN by end of 2026 as patient demand doubles - MSN
Stifel cuts Abeona Therapeutics stock price target on sales timing By Investing.com - Investing.com India
Oppenheimer reiterates Abeona Therapeutics stock rating at Outperform By Investing.com - Investing.com Canada
Stifel cuts Abeona Therapeutics stock price target on sales timing - Investing.com
Abeona Therapeutics Inc (ABEO) Q4 2025 Earnings Call Highlights: - GuruFocus
Abeona Therapeutics Reports 2025 Financial Results, ZEVASKYN Launch Momentum, and $191.4M Cash Position - Minichart
Abeona (ABEO) Fourth Quarter 2025 Earnings Conference Call Transcript - Bitget
ABEO: Strong launch momentum, profitability, and expanding access position ZEVASKYN for growth - TradingView
Abeona (ABEO) Q4 2025 Earnings Call Transcript - The Globe and Mail
Abeona Therapeutics Q4 Earnings Call Highlights - MarketBeat
ABEO: 2025 marked a profitable year with ZEVASKYN's launch, expanding access, and robust financials - TradingView
Earnings call transcript: Abeona Therapeutics Q4 2025 shows revenue growth - Investing.com
Abeona Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Abeona Therapeutics 2025 Financial Results: Annual Profit and Q4 BeatNews and Statistics - IndexBox
Abeona Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Abeona Therapeutics (ABEO) Reports Mixed FY Results with Revenue Beat - GuruFocus
Abeona Therapeutics FY income from operations USD -89.448 million versus Ibes estimate USD -78.4 million - marketscreener.com
Abeona Therapeutics (NASDAQ:ABEO) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
ABEO Exceeds Revenue Expectations with Strong Biopsy and Treatme - GuruFocus
ABEONA THERAPEUTICS ($ABEO) Releases Q4 2025 Earnings - Quiver Quantitative
The latest financial data released by biotechnology company Abeona Therapeutics Inc shows its annual operating income recorded at -89.448 millions USD. - Bitget
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):